Home ›
Trademark Categories ›
Pharmaceuticals ›
2014 ›
VI ›
VIFELZAN
Trademark search for:
VIFELZAN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-06-15 — Application filed
2021-07-29 — Sn assigned for sect 66a subseq desig from ib
2021-08-09 — Application filed
2021-08-10 — Application filed
2021-08-14 — Application filed
2021-09-15 — Teas change of owner address received
2021-09-15 — Teas change of domestic representatives address
2021-09-15 — Attorney/dom.rep.revoked and/or appointed
2021-09-15 — Teas revoke/app/change addr of atty/dom rep received
2021-09-15 — Teas change of correspondence received
2021-09-15 — Applicant/correspondence changes (non-responsive) entered
2021-09-28 — Assigned to examiner
2021-09-28 — Final disposition recorded
2021-09-29 — Office action issued
2021-10-21 — Office action issued
2021-10-24 — Office action issued
2021-11-23 — Office action issued
2021-12-13 — Office action issued
2021-12-13 — Correspondence received in law office
2021-12-14 — Teas/email correspondence entered
2021-12-15 — Approved for pub - principal register
2021-12-28 — Withdrawn from pub - og review query
2022-01-19 — Notification of notice of publication e-mailed
2022-02-08 — Published for opposition
2022-02-08 — Official gazette publication confirmation e-mailed
2022-04-26 — Registered-principal register
2022-07-26 — Final disposition recorded
2022-09-01 — Final disposition recorded
2022-09-01 — Final disposition recorded
2022-09-20 — Final disposition recorded
2024-10-22 — Final status recorded
2025-05-22 — Death of international registration
2025-05-22 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
NOVARTIS AG
NOVARTIS AG
NOVARTIS AG
Correspondent
Maury M. Tepper, III Tepper & Eyster, PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
